pepsico glp 1 How is adapting to consumer use of GLP-1 drugs Expectations on every calorie—PepsiCo's CEO

No clinic visit

Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study

The University of Rhode Island received $25,000 for Microbiome editing to reduce bacterial virulence, led by Amanda Alker, assistant professor of pharmacy

Initial impairment post-intake was noted, receding over time, with subsequent emergence of positive effects (Bonnieux et al., 2023)

Reframing Weight Regain After VSG as a Metabolic Issue One of the key takeaways from Dr